Financials
- Fiscal year
- 2025
- Total assets
- €6.2m
- Profit
- €611,794
- Solvency
- 51.5%
Total assets▼ 3.4%
Net result
20232025
Summary
NEXT GEN PHARMA is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €3.2m and a net result of €611,794. Equity is growing by ~25.3% per year across the filed fiscal years. Its solvency ranks better than 50% of 5651 sector peers (fiscal year 2025). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
Overview
What they do
Activities of holding companies
NACE 64210Holdings NACE 64200
#4 company by total assets in Zottegem, Finance and insurance sector1 site
How big
€6.2mtotal assets 2025
- Equity
- €3.2m
- Profit
- €611,794
Turnover not published (abridged schema)
Financially healthy?
Financial institution: outside the modelProbability: sector outside the model
Who decides
- Holdings
- 1
Accounts filed 7 d late0 of 1 deed read
SignalsFiled after the deadlineShow the evidence
Checked score
Outside the general model
Model not applicable to financial institutions
The Checked score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-08-2026, 7 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 3 filingsDeviation from the deadline
2025
7 d late
2024
18 d early
2023
13 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 3 accounts on average 8 days before the deadline; the sector median for financial year 2024 is 14 days before the deadline, and 28% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 19 July (3 of the last 3 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
- Annual accounts filedfiscal year 2025 · abbreviated…
- Annual accounts filedfiscal year 2024 · abbreviated…
- Highest result since 2023net €691,805 ▲36.1%
Key points
By topic
Network & group
- Subsidiaries
- 3
- Holdings
- 1
3 subsidiaries
Timeline
- Events
- 5
- Since
- 2024
- Next accounts
- by 31-07-2027
- 07-08-2026Annual accounts filed
- 13-07-2025Annual accounts filed
- 31-12-2024Highest result since 2023
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Activities of holding companiesNACE 64210
- Founded
- 02-12-2022
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What changed in the latest annual accounts?What changed What held for this company on a given day: board, seat, name?Company as of a date
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.